Adjuvant treatments in biliary tract cancer: an analysis based on restricted mean survival time

被引：2
|
作者：
Messori, Andrea [1 ]
Bartoli, Laura [1 ]
Trippoli, Sabrina [1 ]
机构：
[1] Toscana Region Hlth Serv, HTA Unit, Florence, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2020年 / 52卷 / 10期
关键词：
CHEMOTHERAPY; GEMCITABINE;
D O I：
10.1016/j.dld.2020.05.021
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1208 / 1209
页数：2
相关论文
共 50 条
  • [1] Postoperative adjuvant treatments for biliary tract cancer
    Furuse, Junji
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2008, 15 (05): : 463 - 467
  • [2] Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis
    Mauro, Ezequiel
    Sanduzzi-Zamparelli, Marco
    Sauri, Tamara
    Soler, Alexandre
    Iserte, Gemma
    Fortuny, Marta
    Forner, Alejandro
    [J]. CANCERS, 2024, 16 (11)
  • [3] On the Restricted Mean Survival Time Curve in Survival Analysis
    Zhao, Lihui
    Claggett, Brian
    Tian, Lu
    Uno, Hajime
    Pfeffer, Marc A.
    Solomon, Scott D.
    Trippa, Lorenzo
    Wei, L. J.
    [J]. BIOMETRICS, 2016, 72 (01) : 215 - 221
  • [4] Cancer Biology and Survival Analysis in Cancer Trials: Restricted Mean Survival Time Analysis versus Hazard Ratios
    A'Hern, R. P.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (09) : E75 - E80
  • [5] Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards
    Yang, Zijing
    Wu, Hongji
    Hou, Yawen
    Yuan, Hao
    Chen, Zheng
    [J]. Computer Methods and Programs in Biomedicine, 2021, 207
  • [6] Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards
    Yang, Zijing
    Wu, Hongji
    Hou, Yawen
    Yuan, Hao
    Chen, Zheng
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2021, 207
  • [7] Analysis of stage III stomach cancer using the restricted mean survival time
    Kim, Bitna
    Lee, Minjung
    [J]. KOREAN JOURNAL OF APPLIED STATISTICS, 2021, 34 (02) : 255 - 266
  • [8] First-line treatments for chronic lymphocytic leukemia: Analysis of 7 trials based on the restricted mean survival time
    Bartoli, Laura
    Ferracane, Elisa
    Trippoli, Sabrina
    Messori, Andrea
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (04) : 322 - 327
  • [9] A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer
    Yamanaka, Kenya
    Hatano, Etsuro
    Kanai, Masashi
    Tanaka, Shiro
    Yamamoto, Keiichi
    Narita, Masato
    Nagata, Hiromitsu
    Ishii, Takamichi
    Machimoto, Takahumi
    Taura, Kojiro
    Uemoto, Shinji
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 485 - 489
  • [10] A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer
    Kenya Yamanaka
    Etsuro Hatano
    Masashi Kanai
    Shiro Tanaka
    Keiichi Yamamoto
    Masato Narita
    Hiromitsu Nagata
    Takamichi Ishii
    Takahumi Machimoto
    Kojiro Taura
    Shinji Uemoto
    [J]. International Journal of Clinical Oncology, 2014, 19 : 485 - 489
12345